MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.84

+0.8%

Nov 10 3:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	12/14/2006 3:11:42 PM
	of 2240

NEW YORK, Dec 14 (Reuters) - Bristol-Myers Squibb said on Thursday it could seek approval for as many as three new cancer drugs by next year, including treatments for melanoma and cancers of the breast and bladder. The company said it plans to seek approval next year for breast cancer drug ixabepilone, and to seek approvals by late 2007 or 2008 for bladder cancer treatment vinflunine and melanoma drug ipilimumab. The timelines were given at a media tour of the company's oncology laboratories in New Brunswick, New Jersey by Robert Kramer, vice president of oncology and immunology drug discovery. Kramer singled out ipilimumab as perhaps the most exciting of the three drugs, noting that current treatments for melanoma, such as interferon, have only minimal effectiveness. "Ipilimumab would be an advance over current treatments," he said, noting that the medicine is designed to put a brake on a protein that hampers the immune system.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next